Mustang Bio (MBIO) Announces $12.8M Grant to Fund Phase 1 Trial of CAR T Therapy MB-101 in Malignant GliomaStreetInsider.comMustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a Fortress Biotech, Inc. (NASDAQ: FBIO) company focused on the development of nove… Continue reading
News-Medical.net |
Agilent collaborate with Doulix to promote SureVector cloning kits
News-Medical.net Double Helix Technologies (Doulix) announced a collaboration with Agilent Technologies Inc. to promote Agilent’s SureVector next-generation cloning kits through Doulix’s web platform. Through this partnership, synthetic biologists will be able to … |
|
Researchers Develop Improved Technique for Creating Brain Tissue from Stem Cells
Scicasts (press release) (blog) Los Angeles, CA (Scicasts) — UCLA researchers have developed an improved technique for creating simplified human brain tissue from stem cells. Because these so-called “mini brain organoids” mimic human brains in how they grow and develop, they’re … |
Labiotech.eu (blog) |
Horama’s Gene Therapy to Cure Retinitis Pigmentosa Enters the Clinic
Labiotech.eu (blog) Horama has been authorized to start a Phase I/II trial in France testing HORA-PDE6B, a one-off gene therapy with the potential to cure retinitis pigmentosa. |